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INTRODUCTION: Noninvasive positive pressure has been used to treat several diseases. However, the physiological response of 
the cardiac autonomic system during bilevel positive airway pressure (Bilevel) remains unclear. 
OBJECTIVE: The aim of this study was to evaluate the heart rate variability (HRV) during Bilevel in young healthy subjects. 
METHODS: Twenty men underwent 10-minute R-R interval recordings during sham ventilation (SV), Bilevel of 8-15 cmH2O 
and Bilevel of 13-20 cmH2O. The HRV was analyzed by means of the parallel R-R interval (mean R-Ri), the standard deviation 
of all R-Ri (SDNN), the root mean square of the squares of the differences between successive R-Ri (rMSSD), the number of suc-
cessive R-Ri pairs that differ by more than 50 milliseconds (NN50), the percentage of successive R-Ri that differ by more than 50 
milliseconds (pNN50), the low frequency (LF), the high frequency (HF) and SD1 and SD2. Additionally, physiological variables, 
including blood pressure, breathing frequency and end tidal CO2, were collected. Repeated-measures ANOVA and Pearson cor-
relation were used to assess the differences between the three studied conditions and the relationships between the delta of Bilevel 
at 13-20 cmH2O and sham ventilation of the HRV indexes and the physiological variables, respectively. 
RESULTS: The R-Ri mean, rMSSD, NN50, pNN50 and SD1 were reduced during Bilevel of 13-20 cmH2O as compared to SV. An 
R-Ri mean reduction was also observed in Bilevel of 13-20 cmH2O compared to 8-15 cmH2O. Both the R-Ri mean and HF were 
reduced during Bilevel of 8-15 cmH2O as compared to SV, while the LF increased during application of Bilevel of 8-15 cmH2O as 
compared to SV. The delta (between Bilevel at 13-20 cmH2O and sham ventilation) of ETCO2 correlated positively with LF, HF, 
the LF/HF ratio, SDNN, rMSSD and SD1. Acute application of Bilevel was able to alter the cardiac autonomic nervous system, 
resulting in a reduction in parasympathetic activity and an increase in sympathetic activity and higher level of positive pressure 
can cause a greater influence on the cardiovascular and respiratory system.
KEYWORDS: Heart rate; Neural control; Heart rate variability; Noninvasive positive pressure ventilation; Physiological responses.
INTRODUCTION
Noninvasive positive pressure ventilation (NiPPV) 
has gained widespread acceptance for the support of 
cardiovascular1-3 and respiratory dysfunction.4 NiPPV is used 
to improve gas exchange and the ventilatory pattern, reduce 
respiratory work and increase tidal volume.3 Some modes of 
NiPPV have become standard therapy for treatment in acute 
care settings,5 by reducing the respiratory effort, the need for 
intubation, the length of hospital stay6 and mortality,7 while 
improving respiratory mechanics and alveolar ventilation.8
However, the NiPPV application ordinarily used in 
respiratory interventions may affect intrathoracic 
hemodynamic and cardiovascular stability by reducing venous 
return and right ventricular end-diastolic volume.9,10 These 
effects can lead to a reduction in cardiac output and result in 
cardiac autonomic adjustments to maintain homeostasis.10 
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Respiratory phases during normal breathing, left stroke 
volume and arterial blood pressure variations are sensed 
by baroreceptors. These baroreceptors provoke parallel 
R-R interval (R-Ri) changes by means of baroreflex 
physiology.11,12 In addition, hemodynamic oscillations during 
normal (negative pressure) respiration are predominantly 
due to changes in intrathoracic pressure.13 In this context, 
the alterations caused by NiPPV application can also 
produce physiological responses in cardiac beat intervals and 
influence the autonomic neural control of heart rate (HR). 
Recent studies14 have demonstrated that short-term 
administration of continuous positive airway pressure 
(CPAP) in normal subjects causes significant alterations 
in R-Ri variability. However, we have not encountered any 
studies on the effects of bilevel positive airway pressure 
ventilation (Bilevel), which produces biphasic respiratory 
cycles (inspiratory and expiratory pressures), nor on the 
possibility of different pressure levels differentially affecting 
hemodynamic responses and thus cardiac autonomic control.
Bilevel has commonly been used as an effective means 
for the management of several diseases.14,15 However, 
its physiological responses at different levels remain 
to be clarified. Therefore, the aim of the present study 
was to noninvasively evaluate cardiac autonomic neural 
control by examining heart rate variability (HRV) during 
Bilevel application and to correlate HRV alterations with 
physiological measurements. The present study tested the 
hypothesis that acute Bilevel application can modify HRV 
in healthy young men and, based on a previous study16, that 
physiological variables can modulate HRV changes.
MATERIAL AND METHODS
Study population
A total of 20 non-smoking, healthy young men were 
evaluated and included in this study. All volunteers 
underwent anamnesis, physical and clinical examination, 
a 12-channel electrocardiogram and incremental exercise 
testing. Subjects with heart rhythm disorders, obstructive 
or restrictive respiratory disturbances and acute or chronic 
illness evidence were excluded from the study. None of the 
subjects were receiving acute or chronic medications. The 
study protocol was approved by the Federal University of 
São Carlos ethics committee and all subjects signed a written 
consent form prior to the initiation of the study. 
Design and procedures 
This was a prospective, double-blind, randomized 
controlled trial. 
Experimental procedures
Experimental procedures were performed on a single 
day and always began at the same time of day (7:00 AM) 
at a room temperature between 22°C and 24°C and a 
relative air humidity between 50 and 60%. Each subject 
was instructed to avoid caffeinated and alcoholic beverages 
for at least 12 hours before the test and to avoid moderate 
or heavy exercise on the day before the application of 
the protocol. The experiment was performed by two 
investigators. One investigator was aware of the NiPPV 
intervention and operated the device, while the other 
investigator was responsible for the data physiological 
collection and data analysis and was not aware of the 
pressure levels applied.
Heart rate and R-Ri were recorded by the CM5 lead, 
which was chosen to provide higher R wave and lower T 
wave curve electrocardiogram (ECG) signal amplitudes. 
The ECG and HR were obtained from a one-channel heart 
monitor (Ecafix TC500, São Paulo, Brazil) and processed 
using an analog-digital converter (PCI7030/640E, National 
Instruments, Co., Austin, TX, USA), which represents 
an interface between the ECG monitor and a Pentium 
III microcomputer. The R-Ri (milliseconds (ms)) was 
calculated using specific software.17 Before starting the 
experimental procedure, the subjects were asked to remain 
in a sitting position for 15 minutes to adjust themselves to 
the environmental conditions.
Data collection was performed during spontaneous 
breathing (sham ventilation), as well as during ventilatory 
assistance, delivered by a Bilevel ventilator mode (BiPAP S, 
Respironics Inc, Murrysville, PA) applied via a nasal mask 
(chosen previously by volunteers as the more comfortable 
mask) under the following conditions for 10 minutes each:
1) Sham Ventilation (SV): HR and R-Ri were recorded 
during simulated ventilation with the same nasal mask and 
device, but without positive pressure application. 
2) Expiratory positive airway pressure (EPAP) of 8 
cmH2O and inspiratory positive airway pressure (IPAP) of 
15 cmH2O (hereafter referred to as Bilevel of 8-15): HR and 
R-Ri were recorded during Bilevel application with levels 
titrated to 8 cmH2O and 15 cmH2O of EPAP and IPAP, 
respectively. 
3) EPAP of 13 cmH2O and IPAP of 20 cmH2O (hereafter 
referred to as Bilevel of 13-20): HR and R-Ri were recorded 
during Bilevel application with levels titrated to 13 cmH2O 
and 20 cmH2O of EPAP and IPAP, respectively. 
Subjects were randomly allocated to the three conditions 
above, by the drawing of shuffled, opaque, coded envelopes 
that were opened immediately before starting the procedure. 
The subjects were not aware of the different levels applied.
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A capnometer (BCI 1050, Waukesha, USA) was used 
to monitor the breathing frequency (BF) and end-tidal of 
carbon dioxide (ETCO2), while peripheral oxygen saturation 
(SpO2) was obtained by pulse oximetry (OX-P-10, Emai 
Transmai, Sao Paulo, Brazil). Systolic blood pressure (SBP) 
and diastolic blood pressure (DBP) were measured by an 
indirect method, using a sphygmomanometer, at the end 
of each studied condition (SV and Bilevel application at 
both levels applied) in order to investigate the influence of 
positive pressure on these variables. For all conditions, the 
subjects were instructed to breathe calmly while SpO2, BF 
and ETCO2 were monitored.
Before starting the HR and R-Ri recordings, there was 
an adaptation period for each of the levels of ventilatory 
assistance of approximately 10 minutes for each subject, as 
well as an interval period of 15 minutes between the study 
conditions, in order for physiological variables to return to 
baseline values.
HRV analysis 
All artifacts were reviewed by visual inspection on the 
computer display. Only segments with >90% pure sinus 
beats were included in the final analysis. The data were 
entered into Kubios HRV Analysis software (MATLAB, 
version 2 beta, Kuopio, Finland). 
HRV was analyzed with linear statistical measures in 
time-and frequency-domain. The mean of all R-Ri (R-Ri 
mean), the standard deviation of all R-Ri in ms (SDNN, 
which reflects all of the cyclic components responsible for 
variability in the period of recording and is a estimate of 
overall HRV18), the root mean square of the squares of the 
differences between successive R-Ri in ms (rMSSD), the 
number of successive R-Ri pairs that differ by more than 50 
ms (NN50) and the percentage of successive R-Ri pairs that 
differ by more than 50 milliseconds (pNN50) were computed 
as time domain measures, with the last three indexes used to 
express parasympathetic activity.18
In the frequency domain, the power spectral components 
were reported using Fast Fourier Transform at low frequency 
(LF) and high frequency (HF) in normalized units. The LF 
component is representative of sympathetic activity, although 
it is also influenced by parasympathetic components.18,19 
The HF component is representative of the parasympathetic 
component18 and the LF/HF ratio represents sympathetic 
vagal balance.19
In addition, nonlinear statistical measures by a Poincaré 
plot were analyzed with the standard deviation of the 
Poincaré plot perpendicular to the line-of-identity and related 
to short-term variability that is mainly caused by RSA (SD1) 
in ms, which represents a measure of parasympathetic 
nervous system activity, and the standard deviation of the 
Poincaré plot along the line-of-identity (SD2), which is 
representative of the total HRV.20 
Statistical analysis 
Data were submitted to a frequency distribution analysis 
test (Shapiro-Wilk´s), and as it presented normality values, 
the parametric test was applied. Repeated-measures analysis 
of variance (ANOVA) with the Tukey post-test was utilized 
in GraphPad InStat for Windows program, version 3.0 
(1994-1999). The level of significance was set at p<0.05. 
A Pearson correlation analysis was employed to assess the 
relationships between the delta of higher Bilevel application 
(13-20 cmH2O) and the SV of the HRV indexes and of 
the physiological variables (blood pressure, breathing rate 
and end-tidal CO2). Employing data from a pilot study, the 
sample size was determined using a 5% significance level, a 
power of 80% and an expected mean difference between SV 
and Bilevel for a mean heart rate of approximately 5 beats 
per minute (bpm) and a variability of 10 bpm. The estimated 
sample size was determined to be 14 subjects per group. 
(StatCalc version 6.0.1 2009).
RESULTS
Twenty healthy young men that were referred to the 
study were eligible. The following characteristics describe 
the subjects: mean age of 23±2.2 years, mean weight of 
75±11.3 kg, mean height of 182±6.7 cm and a mean body 
mass index of 23±2.4 kg/m2.
Table 1 shows the mean HR, BF, ETCO2, SBP, DBP and 
SpO2 of the study subjects. Compared to SV, both Bilevel 
conditions resulted in a significant increase in HR, BF and 
SpO2 and a decrease in ETCO2. The application of Bilevel 
of 13-20 cmH2O increased HR and decreased ETCO2, 
compared to the lower levels of positive pressure applied. 
HRV changes: In terms of the HRV variables during 
SV and Bilevel application at two different levels, the 
application of 13-20 cmH2O was associated with a reduction 
in the R-Ri mean, RMSSD, NN50, pNN50 and SD1 as 
compared to SV. There was also a reduction in the R-Ri 
mean with the application of 13-20 cmH2O as compared to 
the 8-15 cmH2O Bilevel application. Compared to SV, the 
8-15 cmH2O Bilevel application resulted in significantly 
lower values of the R-Ri mean and HF, while increasing the 
value of LF (Table 2).
The delta of ETCO2 positively correlated with LF 
(r=0.47), HF (r=0.47), LF/HF (r=0.47), SDNN (r=0.45), 
RMSSD (r=0.47) and SD1 (r=0.47). All correlations have a 
p value less than 0.05.
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DISCUSSION
Summary of Findings
The present study evaluated the acute effects of NiPPV 
on HRV and other physiological variables in healthy young 
men. The main findings were that Bilevel application is able 
to modify HRV and physiological variables. In addition, 
we found that a higher level of positive pressure can cause 
a greater influence on the cardiovascular and respiratory 
system. Furthermore, we observed that ETCO2 may 
modulate the HRV indexes. 
HRV Changes during Bilevel Application 
The present study shows that Bilevel application, at 
different levels, significantly modifies HRV in young healthy 
subjects. A Bilevel application of 8-15 cmH2O was able to 
increase sympathetic response and decrease parasympathetic 
activity. The higher level of positive pressure provoked a 
parasympathetic reduction with alterations of almost all 
vagal representative indexes, compared to SV. Moreover, 
when compared to the lower pressure application, the higher 
level of positive applied pressure caused a greater influence 
on the cardiovascular system as seen by a greater reduction 
in the mean R-Ri.
Previous data have demonstrated that the autonomic 
nervous system is significantly active during the application 
of positive airway pressure ventilation10. Heindl et al.21 
observed an increase in muscle sympathetic nerve activity 
during short-term application of CPAP at 10 cmH2O in 
healthy subjects. In contrast to our study using Bilevel, the 
Table 2 - Heart rate variability of healthy volunteers during sham ventilation (SV) and Bilevel ventilation (BV) 
SV N= 20 BV of 8-15 cmH2O N= 20 BV of 13-20 cmH2O N= 20
Time domain
Mean RR (ms) 919.2±109.2 866.4±102.7 * 826.9±99.4 †‡ 
SDNN (ms) 54.1±23.4 56.5±26.6 49.3±20.6
rMSSD (ms) 50.2±32.5 45.6±29.4 38.9±18.9 †
NN50 (ms) 81±71.2 68.2±60.2 51.1±40.1 †
pNN50 (%) 26.2±22.9 21.7±19.5 17.1±13.3 †
Nonlinear
SD1 (ms) 35.8±23.1 32.6±20.9 27.9±13.5 †
SD2 (ms) 85.4±32.7 93.1±40.3 85.7±31.8
Frequency Domain
LF (nu) 60.1±20.5 72.5±21.7 * 68.1±21.4
HF (nu) 39.9±20.5 27.5±21.7 * 31.9±21.4
LF/HF 3.7±7.5 5.2±4.3 4.2±4
Mean RR= the mean of R-R intervals, in ms; SDNN= standard deviation of all R-R intervals, in ms; rMSSD= root mean square of the squares of the 
differences between successive R-Ri, in ms; NN50= number of successive R-Ri interval pairs that differ by more than 50 ms; pNN50= percentage of suc-
cessive R-Ri pairs that differ by more than 50 ms; SD1= the standard deviation of the Poincaré plot perpendicular to the line-of-identity, in ms; SD2= the 
standard deviation of the Poincaré plot along the line-of-identity, in ms; LF= low frequency, in normalized units; HF= high frequency, in normalized units; 
LF/HF= ratio of low frequency to high frequency. * Bilevel of 8-15 cmH2O versus SV; † Bilevel of 13-20 cmH2O versus SV; ‡ Bilevel of 13-20 cmH2O 
versus Bilevel of 8-15 cmH2O. Repeated-measures analysis of variance (ANOVA) with the Tukey post-test. Data expressed in mean and standard deviation.
Table 1 - Physiological data of the healthy volunteers during sham ventilation (SV) and Bilevel ventilation (BV) 
SV N= 20 BV of 8-15 cmH2O N= 20 BV of 13-20 cmH2O N= 20
HR (bpm) 66.4 ± 7.2 70.6 ± 7.8 * 73.9 ± 8.3 †‡ 
BF (bpm) 13 ± 2.3 15 ± 2.9 * 15 ± 3.6 † 
 ETCO2 (mmHg) 40.2 ± 5.2 30.5 ± 6.1 * 25.2 ± 5.3 †‡ 
SBP (mmHg) 104.7 ± 10.4 102.5 ± 10.8 103.5 ± 12.6
DBP (mmHg) 67.7 ± 7.5 70.5 ± 9.2 71 ± 8.7
SpO2 (%) 96.5 ± 1.1 97.2 ± 0.7 * 97.4 ± 0.9 †
HR= heart rate, presented in beats per minute (bpm); BF= breathing frequency, in breathes per minute (bpm); ETCO2= end-tidal of carbon dioxide, in 
millimeters of mercury (mmHg); SBP= systolic blood pressure, in mmHg; DBP= diastolic blood pressure, in mmHg; SpO2:= peripheral oxygen saturation, 
presented as a percentage; * Bilevel of 8-15 cmH2O versus SV; † Bilevel of 13-20 cmH2O versus SV; ‡ Bilevel of 13-20 cmH2O versus Bilevel of 8-15 
cmH2O. Repeated-measures analysis of variance (ANOVA) with the Tukey post-test. Data expressed in mean and standard deviation.
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majority of previous studies have investigated the effects of 
CPAP modality on the cardiovascular system.
This is the first study to compare the effects of two 
levels of Bilevel on cardiac autonomic nervous control. 
We observed that the magnitude of cardiovascular, 
hemodynamic and pulmonary responses can be related to 
the level of positive pressure applied. Some authors14 have 
previously observed a difference in the HRV responses 
in healthy subjects when different levels of CPAP were 
applied. A greater modification was observed when high 
applied levels (>15 cmH2O) were used. These data suggest, 
in accordance with our results, that the magnitude of cardiac 
autonomic responses can be influenced by differences in the 
levels of positive pressure applied. 
The effects  of  venti lat ion mechanics on the 
cardiovascular system resulting from the NiPPV application 
can explain the HRV alterations. Increased intrathoracic 
pressure application can produce significant hemodynamic 
alterations, such as a reduction in venous return and stroke 
volume with a tendency to decrease cardiac output.9,22 These 
hemodynamic alterations are then sensed by the carotid sinus 
and aortic baroreceptors, and the fluctuations in the cardiac 
filling are sensed by cardiac receptors.13 Cardiopulmonary 
receptors represent another group of baroreceptors that 
regulate sympathetic outflow.23 Therefore, a reduction in 
venous return and cardiac filling pressures can unload all of 
these cardiopulmonary baroreceptors. Unloading of these 
baroreceptors results in cardiac autonomic adjustments in 
healthy subjects, as physiological responses resulting from 
hemodynamic alterations,24 which was observed in our study.
Besides the acute use of NiPPV in some eventual 
clinical conditions, this intervention has been routinely 
applied to treat chronic diseases, such as obstructive sleep 
apnea syndrome,25 chronic obstructive pulmonary disease 
(COPD)26,27 and congestive heart failure.22 Studies in 
patients with several different diseases that were submitted 
to short-term and long-term NiPPV have demonstrated 
different HRV responses. Kaye et al.22 found a reduction in 
cardiac sympathetic tone in patients with congestive heart 
failure submitted to a short-term nasal CPAP of 10 cmH2O. 
Maser et al.28 observed an improvement in vagal tone and 
cardiovascular autonomic function in patients with sleep-
disordered breathing after six weeks of treatment with CPAP. 
On the other hand, Borghi-Silva et al.29 found a reduction 
in parasympathetic activity and an increase in sympathetic 
activity during Bilevel ventilation in COPD patients that 
were submitted to similar pressure levels used in our study.
We know that it is impossible to extend the results of 
our study to patients with disease whose HRV responses 
may differ from those with normal clinical conditions 
(as demonstrated in the literature). However, our study is 
of interest in clarifying the HRV physiologic responses 
resulting from the influence on the hemodynamic and 
cardiac autonomic nervous system produced by the 
application of this modality. The present study is especially 
important considering the lack of studies performed with 
Bilevel and the applicability of this kind of intervention for 
some chronic diseases (like COPD) and in acute clinical 
conditions with subjects who are mainly without some 
previous disease or instability.
Moreover, we reinforce the importance of the applied 
level of positive airway pressure. Considering the impact of 
pressure levels on the cardiac autonomic nervous system, 
care should be applied when selecting the level of pressure 
to apply. The level of applied pressure should be selected 
according to the necessity required by each clinical condition. 
Higher or lower levels of pressure must be chosen in order to 
provide the best functionality of the cardiovascular system. 
Physiological Variables during Bilevel Application
As demonstrated in Table 1, physiological parameters 
were modified by Bilevel application at both applied levels 
as compared to SV. The application of Bilevel at a higher 
level (13-20 cmH2O) also increased HR and decreased 
ETCO2 as compared to the low level (8-15 cmH2O). As 
observed, both pressure levels applied were strong enough 
to improve the gas exchange, as reflected by an increase 
in oxygen saturation and a decrease in ETCO2. These data 
reflect a ventilation improvement.
The HR behavior is directly related to cardiac autonomic 
responses provoked by the effect of positive airway pressure, 
as previously explained. Modifications of the cardiovascular 
system are required in order to maintain the cardiac output, 
which were expressed in our results by an increase of HR 
and a decrease in the mean R-Ri.
Considering the respiratory variables, we should 
expect that when Bilevel is applied, the BF would decrease 
once noninvasive positive pressure ventilation is used to 
reduce the respiratory work and increase the tidal volume. 
However, the increase in this variable between SV and both 
Bilevel applications had no clinical relevance; these values 
were maintained within the normality range and presented 
few modifications. Moreover, the study population was 
composed of young healthy volunteers, from whom we 
can expect a different BF response as compared to patients 
with disease, once they didn´t need a ventilation support. 
The application of positive pressure may have provoked a 
decreased comfort as compared to spontaneous breathing, 
resulting in the tendency to increase the breathing frequency. 
In regards to ETCO2, NiPPV may have increased tidal 
volume and minute ventilation and thus reduce its values. 
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Some authors16 have reported that the autonomic neural 
system areas that control breathing and heart function are 
located close to each other in the brainstem. Thus, CO2 
alterations can mediate, through chemoreceptors, the cardiac 
autonomic control system. Therefore, we can speculate that 
ETCO2 alterations, as well as BF alterations, also contribute 
to HRV responses. This effect can be explained by the 
driving effect of CO2 on ventilation. As a result, we cannot 
exclude the influence of respiratory variables on cardiac 
autonomic modulation, besides the mechanical effects 
previously explained. 
Importantly, we must emphasize that our results suggest 
a greater influence of a higher level of positive pressure on 
respiratory variables, as occurred in HRV responses.
Relationship between HRV and Physiological Data
In regards to the moderate correlations found between 
the delta of the HRV variables and the physiological data, 
we observed that the higher the ETCO2 variation, the greater 
the influence on cardiac autonomic control. Changes in 
breathing patterns due to altered CO2 are known to interact 
with the autonomic cardio-respiratory control system.30 CO2 
concentrations in the blood may affect the firing rate of the 
autonomic nervous system to the respiratory muscles and 
the cardio-respiratory control network. This change in firing 
rate may in turn influence the HRV spectrum.28 Similar to 
our results, a decrease in HF power was found to be related 
to low CO2 breathing. In this context, our study suggests 
that ETCO2 variation can modulate the autonomic nervous 
system as well as HRV responses.
Study Implications 
Understanding the physiological effects of NiPPV and 
its influence on the cardiac autonomic nervous system 
in healthy volunteers is important to clarify how positive 
pressure, applied at different levels, can alter HRV in a 
healthy cardiovascular system. While it is difficult to extend 
the results of our study to patients affected with disease, our 
findings presented here should be considered when choosing 
the best and safest therapeutic treatment of patients with 
cardiopulmonary conditions, as well as those with eventual 
acute clinical situations without previous disease or instability. 
Our data suggest that care should be taken when determining 
the levels of positive pressure to apply, according to the 
physiological adjustments and autonomic response.
Study Limitations
Due to the noninvasive nature of our study, several 
methodological aspects need further clarification. Although it 
was not possible to directly measure the tidal volume in this 
study, we believe that this variable could have an important role 
in the cardiac autonomic control alterations that we observed.
Secondly, we measured the cardiac autonomic nervous 
system control of HR by HRV, a noninvasive measurement. 
Nonetheless, this important tool has been validated by 
previous pharmacologic blockage.18,19 
Another important issue is the time period of Bilevel 
application used in the present study. Our study results 
were limited to short-term application of positive pressure, 
which allowed us to evaluate only the acute effects of this 
ventilatory modality. Such short-term NiPPV is already 
routinely applied during respiratory therapy intervention 
sessions for inpatients and outpatients with acute and chronic 
dysfunctions in care settings.31,32 However, it would be 
interesting to investigate the long-term effects of different 
levels of positive pressure on the cardiac autonomic nervous 
system. We hypothesize that the long-term effects could be 
different from those found in the present study. 
Moreover, we only studied healthy subjects. We cannot 
completely extrapolate our results to real-life patients with 
disease, whose HRV responses may be different from those 
with normal clinical conditions. Nevertheless, our study 
intended to clarify the HRV physiologic responses resulted 
from the application of Bilevel, considering its impact on 
cardiac autonomic nervous system, particularly during 
higher levels. In this context, we wanted to reinforce the 
importance of the level applied and the care required for 
each clinical condition.
CONCLUSION
In summary, the acute application of Bilevel was able 
to alter cardiac autonomic nervous system function, as 
well as physiological variables, in young healthy subjects. 
Compared to a low level of positive pressure, a higher 
level of positive pressure causes a greater influence on the 
cardiovascular and respiratory system. Moreover, ETCO2 
strongly modulates HRV of these subjects. 
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